BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17496536)

  • 1. A prospective assessment of cytomegalovirus immune evasion gene transcription profiles in transplant patients with cytomegalovirus infection.
    Humar A; Kumar D; Gray M; Moussa G; Venkataraman S; Kumar R; Tipples GA
    Transplantation; 2007 May; 83(9):1200-6. PubMed ID: 17496536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
    Greijer AE; Verschuuren EA; Dekkers CA; Adriaanse HM; van der Bij W; The TH; Middeldorp JM
    J Infect Dis; 2001 Aug; 184(3):247-55. PubMed ID: 11443549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative competitive NASBA for measuring mRNA expression levels of the immediate early 1, late pp67, and immune evasion genes US3, US6 and US11 in cells infected with human cytomegalovirus.
    Greijer AE; Adriaanse HM; Kahl M; Tacken NM; Oldenburg N; Sijlmans A; van de Crommert JM; Dekkers CA; Sillekens PT; Middeldorp JM
    J Virol Methods; 2001 Aug; 96(2):133-47. PubMed ID: 11445144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation.
    Sia IG; Wilson JA; Groettum CM; Espy MJ; Smith TF; Paya CV
    J Infect Dis; 2000 Feb; 181(2):717-20. PubMed ID: 10669361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset and duration of cytomegalovirus immediate early 1 mRNA expression in the blood of renal transplant recipients.
    Goossens VJ; Christiaans MH; Blok MJ; Terporten PH; Sillekens P; Lukacsi A; Van Hooff JP; Bruggeman CA
    J Med Virol; 2004 Jan; 72(1):94-101. PubMed ID: 14635016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease.
    Humar A; Kumar D; Boivin G; Caliendo AM
    J Infect Dis; 2002 Sep; 186(6):829-33. PubMed ID: 12198618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the R1 element on expression of the US3 and US6 immune evasion genes of human cytomegalovirus.
    Bullock GC; Lashmit PE; Stinski MF
    Virology; 2001 Sep; 288(1):164-74. PubMed ID: 11543669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
    Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
    Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus: host immune modulation by the viral US3 gene.
    Liu Z; Winkler M; Biegalke B
    Int J Biochem Cell Biol; 2009 Mar; 41(3):503-6. PubMed ID: 18992841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation.
    Ghisetti V; Barbui A; Franchello A; Varetto S; Pittaluga F; Bobbio M; Salizzoni M; Marchiaro G
    J Med Virol; 2004 Jun; 73(2):223-9. PubMed ID: 15122796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus US3 gene expression is regulated by a complex network of positive and negative regulators.
    Biegalke BJ
    Virology; 1999 Sep; 261(2):155-64. PubMed ID: 10497101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease.
    Humar A; Kumar D; Gilbert C; Boivin G
    J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
    Garrigue I; Boucher S; Couzi L; Caumont A; Dromer C; Neau-Cransac M; Tabrizi R; Schrive MH; Fleury H; Lafon ME
    J Clin Virol; 2006 May; 36(1):72-5. PubMed ID: 16481215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
    Franco A; Serrano R; Gimeno A; de Juan J; Merino E; Jiménez del Cerro L; Olivares J
    Nefrologia; 2007; 27(2):202-8. PubMed ID: 17564566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
    Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
    J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
    Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
    Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of US28 gene expression during active human cytomegalovirus infection in lung-transplant recipients.
    Boomker JM; Verschuuren EA; Brinker MG; de Leij LF; The TH; Harmsen MC
    J Infect Dis; 2006 Jun; 193(11):1552-6. PubMed ID: 16652284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products.
    Park B; Oh H; Lee S; Song Y; Shin J; Sung YC; Hwang SY; Ahn K
    J Immunol; 2002 Apr; 168(7):3464-9. PubMed ID: 11907106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
    Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
    Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.